Kalaris Therapeutics, Inc. Common Stock
KLRS • NASDAQ
Kalaris Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Andrew Oxtoby, with a market cap of $139.2M.
Market Cap$139.2M
CEOAndrew Oxtoby
CountryUnited States of America
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
KLR
Kalaris Therapeutics, Inc. Common Stock FAQ
Common questions about Kalaris Therapeutics, Inc. Common Stock
Kalaris Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 13, 2026.